Ovarian response determines the luteinizing hormone suppression threshold for patients following the gonadotrophin releasing hormone antagonist protocol: A retrospective cohort study

Ovarian response determines the luteinizing hormone suppression threshold for patients following the gonadotrophin releasing hormone antagonist protocol: A retrospective cohort study

Background: Ovarian reactivity to gonadotrophin stimulation varies, and individual adjustments to the timing and dose of gonadotrophin-releasing hormone (GnRH) antagonist administration are necessary to prevent excessive increases and decreases in luteinizing hormone (LH) levels in patients with dif...

Full description

Bibliographic Details
Main Authors:	Qingfang Li, Xiaoqian Zhou, Bingru Ye, Minyue Tang, Yimin Zhu
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Heliyon
Subjects:	AMH Controlled ovarian stimulation GnRH antagonist IVF Luteinizing hormone
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023111418

Similar Items

Comparison of Controlled Ovarian Stimulation Protocols on IVF Outcome in Normal and Poor Responders
by: Deniz Esinler, et al.
Published: (2013-12-01)

Ovarian sensitivity index affects clinical pregnancy and live birth rates in gonadotropin-releasing hormone agonist and antagonist in vitro fertilization cycles
by: Chao Chin Hsu, et al.
Published: (2024-12-01)

Comparison of hCG Versus Gonadotropin-Releasing Hormone Agonist to Induce Oocyte Maturation in Assisted Reproductive Technology Cycles: A Retrospective Cohort Study
by: Gulay Beydilli Nacak, et al.
Published: (2021-08-01)

LH level on trigger day, number of follicles ≥16 mm but <18 mm, and number of retrieved oocytes are independent risk factors for polyspermy in gonadotropin-releasing hormone antagonist protocol
by: Qiongyu Wu, et al.
Published: (2024-12-01)

Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome
by: Cavidan Gülerman, et al.
Published: (2013-12-01)

Effect of progesterone from corpus luteum, intravaginal implant, or both on luteinizing hormone release, ovulatory response, and subsequent luteal development after gonadotropin-releasing hormone treatment in cows
by: Lucas Oliveira e Silva, et al.
Published: (2023-06-01)

Prevention of Ovarian Hyper stimulation Syndrome by using gonadotrophic releasing hormone analogue to induce final ovulation trigger in invitro fertilization cycles
by: Safia Sultana, et al.
Published: (2023-04-01)

Effect of LH level on HCG trigger day on clinical outcomes in patients with diminished ovarian reserve undergoing GnRH-antagonist protocol
by: Qianjie Zhang, et al.
Published: (2024-08-01)

Serum Anti-Müllerian Hormone Levels and Estrous Monitoring of GnRH Agonist Deslorelin-Induced Estrus in Bitches: A Pilot Study
by: Sroisuda Chotimanukul, et al.
Published: (2023-01-01)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
by: Andrea Roberto Carosso, et al.
Published: (2021-03-01)

Micronized natural progesterone (Seidigestan®) vs GnRH antagonists for preventing the LH surge during controlled ovarian stimulation (PRO_NAT study): study protocol of a randomized clinical trial
by: M. Martínez-Moya, et al.
Published: (2024-03-01)

Impact of growth hormone on IVF/ICSI outcomes and endometrial receptivity of patients undergoing GnRH antagonist protocol with fresh embryo transfer: a pilot study
by: Yifan Chu, et al.
Published: (2023-08-01)

Progestin-Primed Ovarian Stimulation versus GnRH Antagonist Protocol for Ovarian Stimulation in IVF: A Prospective Pilot Study
by: Tien K. Le, et al.
Published: (2024-03-01)

Does Basal Morning Luteinizing Hormone (bLH) Predict Central Precocious Puberty (CPP) in Girls?
by: Federico Baronio, et al.
Published: (2024-03-01)

Rapid reduction of adenomyosis coexisting with leiomyoma volume during treatment with Relugolix
by: Keitaro Yamanaka, et al.
Published: (2023-12-01)

Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer
by: Carsten Gründker, et al.
Published: (2021-02-01)

Effects of different gonadotropin preparations in GnRH antagonist protocol for patients with polycystic ovary syndrome during IVF/ICSI: a retrospective cohort study
by: Zhengyan Hu, et al.
Published: (2024-02-01)

Overactivation of GnRH neurons is sufficient to trigger polycystic ovary syndrome-like traits in female miceResearch in context
by: Mauro S.B. Silva, et al.
Published: (2023-11-01)

Progesterone change in the late follicular phase affects pregnancy rates both agonist and antagonist protocols in normoresponders: a case-controlled study in ICSI cycles
by: Berfu Demir, et al.
Published: (2016-05-01)

Association between serum LH levels on hCG trigger day and live birth rate after fresh embryo transfer with GnRH antagonist regimen in different populations
by: Ruiqiong Zhou, et al.
Published: (2023-07-01)

A prediction model for high ovarian response in the GnRH antagonist protocol
by: Yilin Jiang, et al.
Published: (2023-11-01)

Non-inferiority of progestin-primed ovarian stimulation versus GnRH antagonist protocol: A propensity score-weighted analysis
by: Le Duc Thang, et al.
Published: (2024-04-01)

Role of luteinizing hormone urinary levels in the diagnostic and therapeutic management of female central precocious puberty
by: Ilaria Brambilla, et al.
Published: (2023-08-01)

Impact of progesterone concentration on human chorionic gonadotropin trigger day on clinical outcomes with one top-quality cleavage-stage embryo or blastocyst transfer in fresh in vitro fertilization cycles
by: Jianing Xu, et al.
Published: (2023-06-01)

Editorial: Benefits and risks of agonist triggering strategies
by: Jan Tesarik
Published: (2024-12-01)

Meta-analysis of trigger timing in normal responders undergoing GnRH antagonist ovarian hyperstimulation protocol
by: Qijun Xie, et al.
Published: (2024-03-01)

Effects of gonadotropin-releasing hormone antagonist (GnRH-ant) cessation on trigger day in a GnRH-ant protocol: a meta-analysis
by: Xueying Li, et al.
Published: (2025-12-01)

The role of elagolix in ovulation suppression during controlled ovarian stimulation: a retrospective cohort study
by: David Soliman, M.Sc., et al.
Published: (2024-12-01)

Lower serum LH level was related to poor embryo quality and adverse pregnancy outcomes in fixed GnRH antagonist protocol with estradiol pretreatment
by: Ying Chen, et al.
Published: (2024-12-01)

Effect of 200 µg of gonadorelin at the first gonadotropin-releasing hormone of the Resynch-25 on ovarian dynamics and fertility in lactating Holstein cows
by: Iago M.R. Leão, et al.
Published: (2024-05-01)

A STUDY ON THE EFFECTIVENESS OF CLOMIPHENE CITRATE IN COMPARISON TO GNRH ANTAGONIST IN PREVENTING LH SURGE AMONG PATIENTS UNDERGOING OVULATION INDUCTION IN IVF-ICSI
by: Shiuan Yee Tan, et al.
Published: (2018-08-01)

The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer
by: Günter Emons, et al.
Published: (2021-02-01)

Evaluation of the Impact of Letrozole in Combination with the GnRH Antagonist Ovarian Stimulation Protocol in Patients Expected to Have a Poor Ovarian Response (POSEIDON Groups 3 and 4)
by: Bulut Varlı, et al.
Published: (2024-02-01)

Co-administration of GnRH-agonist and hCG (double trigger) for final oocyte maturation increases the number of top-quality embryos in patients undergoing IVF/ICSI cycles
by: Binbin Tu, et al.
Published: (2024-07-01)

LH level on the antagonist administration day as a predictor of the reproductive outcomes in women with normal ovarian function
by: Conghui Pang, et al.
Published: (2023-09-01)

GnRH antagonist impairs the process of embryo implantation by inhibiting motility of endometrial stromal cells through reducing c-kit expression
by: Jun Tan, et al.
Published: (2024-12-01)

Correlation between the number of oocytes and the increase of polyspermy rate in IVF cycles
by: Yating Sun, et al.
Published: (2023-12-01)

The role of elagolix in the suppression of ovulation in donor oocyte cycles
by: Catherine Boniface, M.D., et al.
Published: (2023-06-01)

Effectiveness and safety of GnRH antagonist originator and generic in real-world clinical practice: a retrospective cohort study
by: Mingzhu Cao, et al.
Published: (2024-06-01)

Luteinizing hormone profiles during ovarian stimulation in assisted reproductive treatment
by: Hannah Verschuere, et al.
Published: (2024-12-01)